178 related articles for article (PubMed ID: 33459709)
1. Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
Gnanaprakash M; Staniszewski A; Zhang H; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
J Alzheimers Dis; 2021; 79(4):1813-1829. PubMed ID: 33459709
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice.
Staniszewski A; Zhang H; Asam K; Pitstick R; Kavanaugh MP; Arancio O; Nicholls RE
J Neurosci; 2020 Jun; 40(23):4596-4608. PubMed ID: 32341098
[TBL] [Abstract][Full Text] [Related]
3. PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments.
Nicholls RE; Sontag JM; Zhang H; Staniszewski A; Yan S; Kim CY; Yim M; Woodruff CM; Arning E; Wasek B; Yin D; Bottiglieri T; Sontag E; Kandel ER; Arancio O
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3347-52. PubMed ID: 26951658
[TBL] [Abstract][Full Text] [Related]
4. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
5. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
6. Leucine Carboxyl Methyltransferase 1 (LCMT-1) Methylates Protein Phosphatase 4 (PP4) and Protein Phosphatase 6 (PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes.
Hwang J; Lee JA; Pallas DC
J Biol Chem; 2016 Sep; 291(40):21008-21019. PubMed ID: 27507813
[TBL] [Abstract][Full Text] [Related]
7. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
Sontag JM; Nunbhakdi-Craig V; Montgomery L; Arning E; Bottiglieri T; Sontag E
J Neurosci; 2008 Nov; 28(45):11477-87. PubMed ID: 18987184
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of microRNA-195 contributes to protein phosphatase-2A inactivation in rats with chronic brain hypoperfusion.
Liu CD; Wang Q; Zong DK; Pei SC; Yan Y; Yan ML; Sun LL; Hao YY; Mao M; Xing WJ; Ren H; Ai J
Neurobiol Aging; 2016 Sep; 45():76-87. PubMed ID: 27459928
[TBL] [Abstract][Full Text] [Related]
9. Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
Asam K; Staniszewski A; Zhang H; Melideo SL; Mazzeo A; Voronkov M; Huber KL; Pérez E; Stock M; Stock JB; Arancio O; Nicholls RE
PLoS One; 2017; 12(12):e0189413. PubMed ID: 29253878
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1.
Yao XQ; Li XC; Zhang XX; Yin YY; Liu B; Luo DJ; Wang Q; Wang JZ; Liu GP
FEBS Lett; 2012 Jul; 586(16):2522-8. PubMed ID: 22732552
[TBL] [Abstract][Full Text] [Related]
11. Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
Hu W; Wang Z; Zhang H; Mahaman YAR; Huang F; Meng D; Zhou Y; Wang S; Jiang N; Xiong J; Westermarck J; Lu Y; Wang J; Wang X; Shentu Y; Liu R
Neurotherapeutics; 2022 Mar; 19(2):570-591. PubMed ID: 35286657
[TBL] [Abstract][Full Text] [Related]
12. Leucine Carboxyl Methyltransferase Downregulation and Protein Phosphatase Methylesterase Upregulation Contribute Toward the Inhibition of Protein Phosphatase 2A by α-Synuclein.
Tian H; Lu Y; Liu J; Liu W; Lu L; Duan C; Gao G; Yang H
Front Aging Neurosci; 2018; 10():173. PubMed ID: 29950985
[TBL] [Abstract][Full Text] [Related]
13. Spatial control of protein phosphatase 2A (de)methylation.
Longin S; Zwaenepoel K; Martens E; Louis JV; Rondelez E; Goris J; Janssens V
Exp Cell Res; 2008 Jan; 314(1):68-81. PubMed ID: 17803990
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
15. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.
Liu GP; Wei W; Zhou X; Shi HR; Liu XH; Chai GS; Yao XQ; Zhang JY; Peng CX; Hu J; Li XC; Wang Q; Wang JZ
Mol Ther; 2013 Dec; 21(12):2247-57. PubMed ID: 23922015
[TBL] [Abstract][Full Text] [Related]
16. H
Tang S; Qin F; Wang X; Liang Z; Cai H; Mo L; Huang Y; Liang B; Wei X; Ao Q; Xu Y; Liu Y; Xiao D; Guo S; Lu C; Li X
Cell Biol Int; 2018 Sep; 42(9):1182-1191. PubMed ID: 29752834
[TBL] [Abstract][Full Text] [Related]
17. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
18. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
19. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
20. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
